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Introduction
For people with synaesthesia, stimuli are experienced with unusual secondary associations.
For example, sound-colour synaesthetes experience sound stimuli as accompanied by both auditory and visual (i.e., colour) percepts (Asher et al., 2006) . Synaesthesia tends to be regarded in positive rather than negative terms, and has a range of cognitive and perceptual benefits (e.g., for memory; Yaro and Ward, 2007) . Here, we investigate an observation of unusually high rates of white matter hyperintensities in a group of synaesthetes. These hyperintensities are areas of high intensity on T2-weighted MRI scans of a type compatible with the McDonald (imaging) criteria for the diagnosis of multiple sclerosis (MS; Polman et al., 2003) .
MS is an inflammatory disease of the central nervous system (CNS) with a broad range of perceptual and motor symptoms. It is thought to be caused by environmental risk-factors in combination with genetic susceptibility (Compston and Coles, 2008) . MS is characterised by demyelination, axonal loss and gliosis of white matter (Weiner, 2009) . Diffusion tensor imaging (DTI) shows reduced fractional anisotropy (FA) scores in MS patients, indicating reduced white matter integrity in lesion sites and elsewhere (Roosendaal et al., 2009 ).
Although MS is typically classified as a white matter disorder, grey matter is also affected, with reduced volume common in several areas (Ceccarelli et al., 2008) . If patients present with MRI features suggestive of MS but without overt clinical symptoms, this is termed Radiologically Isolated Syndrome (RIS). From a radiological perspective, MRI scans of RIS and MS are indistinguishable, and it is only the presence of clinical symptoms that differentiates between the two conditions. There is also a clinical relationship between the conditions in that approximately one third of patients with RIS develop MS symptoms within 2-5 years (Granberg et al., 2013) .
Structural differences in white and grey matter also characterise the condition of synaesthesia.
Synaesthetes show both increases and decreases in grey matter volume (Jäncke et al., 2009; Hänggi et al., 2008) and altered coherence of white matter ( Rouw and Scholte, 2007; Hänggi et al., 2011; Jäncke et al., 2009 ). This altered white matter is found in regions implicated by the synaesthetic report, and also elsewhere. For example, synaesthetes experiencing colour sensations show increased FA compared with controls near colour selective region V4 (Rouw and Scholte, 2007) but also show FA increases (Rouw and Scholte, 2007) and decreases (Hänggi et al., 2008) in parietal lobe. The cortical reorganisation of white and grey matter in synaesthesia might call for comparison with MS-RIS, and we ask in this paper whether epidemiological or pathological links might exist between them.
Our question is motivated by a particularly high occurrence of MRI abnormalities consistent with the neuroradiological profile of MS-RIS within synaesthetes who have presented to our laboratories for brain imaging studies. In three independent synaesthete cohorts across three countries (San Diego, USA; Paris, France; Edinburgh, UK) we have opportunistically found clinical and/or radiological indicators suggestive of MS in 1 in 6 synaesthetes, 1 in 10 synaesthetes and 1 in 13 synaesthetes, respectively. Our studies were not initiated with the intention of investigating the prevalence of MS-RIS, but our unexpected findings have led us to evaluate the post-hoc detection of white matter abnormalities in these three participants.
All three affected cases met the McDonald (imaging) criteria for the diagnosis of MS. Subject 1 (USA) has a full diagnosis of MS, while Subjects 2 (France) and 3 (UK) are currently free from clinical symptoms and therefore considered to have RIS. Subjects 2 and 3 were initially flagged by routine protocols in our studies in which neuroradiologists examine T2-weighted axial MRI scans for unanticipated pathology. Subject 1's diagnosis was first suggested by her GP several months after our study, because routine radiological checks were not part of that study's protocol.
Our finding of three cases of MS-RIS among 29 synaesthetes is suggestive of an unusually high rate. However, we must address the possibility that we have inadvertently focussed on just those studies where anomalies were found, rather than all synaesthesia imaging studies to date. Collectively, 29 published studies (see table 2) have scanned 211 synaesthetes (including 6 of our own 29 synaesthetes, described in Hubbard et al., 2005) . Together with our remaining unpublished cases (n=23), this gives 234 synaesthete scans in existence known to us. Outside our cohort of 29 participants, we have been able to ascertain that 80 additional synaesthetes' MRI scans were checked with a similar radiologist protocol, and none revealed anomalous findings of this type 1 . A further 121 were scanned without this protocol and the remaining four scans have an unknown status. The most conservative approach is to assume no cases of pathology in any of the 234 scanned cases, other than the three identified here.
Our methodology below is to evaluate this occurrence of MS-RIS in synaesthetes against appropriate baselines. We first begin with full case descriptions of the three affected synaesthetes. This is followed by a set of analyses which consider the appropriate baselines against which to compare our finding of 3 affected cases (1 MS; 2 RIS). To anticipate our methodologies below, we take the most stringent standards against which to compare our observations (given factors such as the geographic variability of MS, and the sampling method of our studies) and nonetheless find that the number of affected cases is significantly higher than chance would predict.
Empirical Study
In this section we evaluate our three cases of MS-RIS both qualitatively and quantitatively, beginning with a detailed clinical evaluation.
Case-details of affected synaesthetes
Synaesthesia Status: Table 1 shows the synaesthetic status and demographic background of the three synaesthete participants in whom radiological anomalies have been identified. The table shows their synaesthesia phenotypes, and these comprise the following: graphemecolour synaesthesia gives rise to coloured percepts triggered by letters and/or digits (e.g., the letter A might be red; Asher et al., 2006) ; sequence-personality synaesthesia gives rise to complex personifications triggered by the members of linguistic sequences (e.g., Monday might be "female, unfriendly"; Simner & Holenstein, 2007) ; number-space synaesthesia, letter-space synaesthesia and time-space synaesthesia are all variants of the broader category of sequence-space synaesthesia, in which linguistic sequences are perceived in spatial arrays (e.g., the letters A-Z might extend in an undulating line from right-to-left across the visual field; see Simner, 2009 for review). Simner et al., 2006; Eagleman et al., 2007) . In this, participants are required to first report their synaesthetic experiences for a list of provided stimuli (e.g., they report their colours for a list of letters), and they are subsequently retested after some considerable time (e.g., 6 months, for the case scanned in San Diego; see Hubbard et al., 2006 for methodological details). Synaesthetes are identified as those who are significantly more consistent in their reports over time, compared to a group of matched controls who invent/recall analogous associations.
Clinical status of MS-RIS: All three synaesthete participants in question met the McDonald (imaging) criteria for the diagnosis of multiple sclerosis. This requires the presence of one or more T2 weighted high signal lesions in at least two of the following four areas of the CNS: periventricular, juxtacortical, infratentorial or spinal cord. A full diagnosis of MS has been given in the case of one participant, while the other two subjects are currently free from clinical symptoms and are therefore considered to have RIS. The synaesthetic status of each participant is shown in Table 1 above and their clinical status is described here.
Subject 1 (San Diego, USA) was diagnosed with clinically definite relapsing-remitting MS several months after taking part in a synaesthesia study in 2001. A diagnosis of MS was first suggested by this participant's GP because routine radiological checks were not part of that study's protocol. Subsequent neurological follow-up consisting of sagittal and axial T1 FLAIR, axial T2 and axial and coronal T1 weighted MRI scans revealed extensive hyperintensities in both the brain and cervical spine, considered to be pathognomonic for MS.
These white matter lesions, in conjunction with history of clinical symptoms, confirmed this participant's diagnosis of MS. This participant had a total of 16 lesions, in both periventricular and juxtacortical white matter (see Figure 1 ). Periventricular lesions were located in the corpus callosum and in occipital and parietal areas. Juxtacortical lesions were found in the parietal region. Lesions were also detected in the spinal cord. This subject was originally scanned for, but subsequently excluded from, Hubbard et al., 2005 (see Table 2 ). Table 2 ).
Subject 3 (Edinburgh, UK) participated in synaesthesia research in 2008 and her resultant axial T2 MRI scan was also examined routinely by a consultant radiologist to detect unanticipated pathology. Initial examination revealed white matter hyperintensities in the brain of this subject. This T2-weighted MRI scan was independently examined by a second neuroradiologist who confirmed that the number and location of the white matter lesions met the McDonald imaging criteria for diagnosis of MS (see Figure 3 ). Again, this participant has remained free of clinical symptoms since the initial presentation of her abnormal scan. This participant had more than 20 lesions in periventricular and juxtacortical white matter (see Figure 3 ). Periventricular lesions were found in frontal, parietal, temporal and occipital areas.
Juxtracortical lesions were identified in temporal and parietal areas. Infratentorial lesions were also present. This subject was scanned for, and subsequently excluded from, a study by Simner et al., in review (see Table 2 ). Table 2 shows what is to our knowledge all studies that have generated MRI scans from synaesthete participants at the time of writing including all published studies, plus our two unpublished samples. Published articles were retrieved from an all-years search of PubMed using search terms "syn*esthesia" (UK/US spellings) and "MRI", and any additional details on participants shown below that were not available in the literature were retrieved by contact with the authors of these studies.  Members of our study cohort (i.e., studies directed in our labs); 3 anomalies in n=29 scans α A study directed by colleagues outside our labs but JS co-authoring † Routine radiological checks for pathology performed by neurologist and no anomalies found † † Routine radiological checks carried out by a neuroradiologist and no anomalies found ¥ No routine radiological checks for pathology performed
Case-details of all synaesthetes with existing MRI scans

Analysis of the prevalence of MS-RIS cases among scanned synaesthetes against expected baselines.
We have found three cases of MS-RIS in 234 synaesthetes who have self-referred for brain scanning studies across the literature. In order to establish whether the number of affected synaesthetes is statistically significant, we must compare the prevalence of observed cases against a meaningful baseline. Since RIS and MS are indistinguishable, from a radiological perspective, we first consider all three cases as a unified phenomenon. Then, since RIS and MS are different in a clinical/symptomatic sense, we additionally consider the two cases of RIS as a distinct phenomenon. Methodologically speaking, we will take our RIS baseline from a meta-analysis of the prevalence of RIS across all MRI scans described in the imaging literature (and below we describe our very conservative approach in this regard). We will take our MS baselines from rates reported in clinical prevalence studies. Since the prevalence of MS is sex-linked and geographically variable, we have considered that the large majority of all scanned synaesthetes are female (86%) and have come from studies conducted in Europe (94%). Accordingly, we took a female MS prevalence figure for Europe. Again however, since a key aim was to be maximally conservative (i.e., to compare our findings with the highest prevalence rates where possible), we additionally re-analysed our data using the most stringent prevalence rate according to the nationality of the three affected cases (American/French/English). In other words, since the rate of MS is highest in England (vs.
America or France), we used this highest England baseline in a second analysis. Below we describe these baseline-selection procedures in more detail, and the resultant statistical outcomes of our analyses (showing whether MS-RIS is indeed significantly higher in selfreferred synaesthete samples).
Baseline selection, and results:
There is no published combined prevalence of MS-RIS, so we use an additive value from each separately. Our recent meta-analysis (Morris et al., 2009) shows a baseline of RIS in the general population of 57.8/100,000. This figure was based on nine cases of unanticipated WMH considered as definite demyelination, which were found in 15,559 scans reported in the literature. To be conservative here, we will also include three cases of possible demyelination in that meta-analysis, and furthermore, we will consider scans only from self-referred volunteer research participants (giving a total of 12 RIS cases found in 8,441 research scans; Proportion (P) =0.14%, 95% CI [0.08%, 0.25%]; Morris et al., 2009) . We consider only self-referred volunteers because this type of participant is similar to those in our own cohort of synaesthetes, and across the 234 scanned synaesthetes more widely. It is important to consider this method of (self-) referral since it may have elevated the number of RIS cases in our cohort. Specifically, self-referred/volunteer recruitment in any brain imaging study may increase rates of neuropathology by over-recruitment of participants who are seeking covert evaluation for undeclared neurological complaints (Morris et al., 2009 ). In other words, our three affected synaesthetes may have volunteered for our studies in order to assuage personal neurological concerns, and we must therefore compare their number against a baseline that specifically takes this into account. In summary, all these considerations give us a comparative baseline for RIS in the general population of 142/100,000. However, we point out that this baseline is likely to be highly inflated since closer inspection of the data that contributed to our meta-analysis reveals that two-thirds of cases contributing to this figure were found in a single study in which 90.0% of participants were former lead workers with a mean age of 60.1 years (Alphs et al., 2006) . Since the likelihood of detecting WMH increases significantly with age (Smith et al., 2000) and with exposure to neurotoxicants such as lead (Stewart et al., 2006) , the true prevalence of WMH in the general population of self-referred volunteers is likely to be substantially lower than the baseline we are selecting here. Nonetheless, we use this baseline as a maximally conservative estimate (to combine with a suitable estimate for MS prevalence below), for comparison with our synaesthete sample.
The prevalence of MS in the general population is better understood, and known to vary by geographic region (with particularly high rates in Scotland (Sutherland, 1956 ) and by sex:
females approximately 2:1; Pugliatti et al., 2006) . This is of note given our Edinburgh testing study (in which four of 13 participants were Scottish; the remainder travelled from England) and the fact that the scanned synaesthesia population is skewed towards females (F= 201) -as potentially, is synaesthesia in general (e.g., see Ward and Simner, 2005) . Considering the sex and nationality of the 234 scanned synaesthetes (using the location of testing centres as an indicator of nationality for cases unknown to us), an appropriate baseline is the rate of MS in female Europeans (110/100,000 2 ) since synaesthetes were virtually exclusively European (94%, n=220; including four Scots, none of whom showed pathology). This we combined with the baseline for RIS to give an additive RIS-MS baseline of 252/100,000.
Using the exact binomial test, we calculated the probability of obtaining our observed number of MS-RIS cases within scanned synaesthetes, given the expected baseline prevalence estimates generated above. Thus, we estimated the probability of three observations of MS- conservative option given the demographics of our three affected cases (American/French/English).
Combining our three cases has allowed us to consider the shared MRI profile of MS and RIS, and their related clinical progression (Granberg et al., 2013) . However, we might alternatively exclude our case of MS as a separate phenomenon, and consider only our two observations of RIS against all 103 scans with protocols to check for such anomaly (P=1.9%, 95% binomial CI [0.2%, 6.7%]. Taking again our highest RIS baseline (142/100,000), this finding is also highly significant (p=.01). Indeed, taking even the most extreme assumption of no other cases in any synaesthete scanned to date -checked or unchecked --an observation of two cases in 234 (P=0.9%; binomial CI [0.1%, 3.1%]) remains significant (p=.04) 4 .
Discussion
We initially observed three cases showing white-matter hyperintensities compatible with the radiological profile of MS --one case of MS and two of RIS --in 29 synaesthetes from three of our imaging labs across three different countries. We have taken the most conservative approach in assuming no further cases in any synaesthetes scanned to date, placing the prevalence at three affected cases in 234 synaesthetes (1,282/100,000, compared to a population baseline estimate of 252/100,000). Two cases of RIS in 103 brain scans checked for pathologies would, if representative, place the prevalence of RIS in synaesthetes at 1,942/100,000 (compared to a baseline of 142/100,000). These rates are significantly higher 3 Calculation of the rate of female MS in England: There was no available data for female MS prevalence in England per se, and so we calculated this based on the rate of MS in eastern England (153/100,000; the highest regional rate in England reported by Compston et al., 2006) and the male: female ratio of MS (2:1; Compston et al., 2006) in combination with the overall population prevalence of women versus men in the United Kingdom (1.01:1; The World Factbook 2011. Washington, DC: Central Intelligence Agency, 2011). This gives an estimate of female MS in England at 204/100,000.
than expectation, even against our highly conservative baselines. We also specifically controlled for the possibility that our three affected cases may have volunteered for our studies in order to assuage personal neurological concerns. We did this by comparing our RIS cases to a baseline constructed only from studies that included similar, self-referred, volunteer participants. In other words, we compared our rates to studies likely to have just as many 'concerned self-referrers' as our own, rather than to studies using non-voluntary recruitment methods (e.g., work-related health screening; Weber and Kopf, 2004) .
We would like to very clearly acknowledge that we report only a small number of affected cases, and we evidently do not claim that synaesthesia causes MS-RIS. Indeed, our small sample size means we hold back from making any strong claim whatsoever about links between these two conditions. There are many environmental factors thought to contribute to the development of MS and RIS; the evidence we present here suggests having synaesthesia may be one factor that could merit further investigation. Indeed, we have chosen to present our data for two reasons. The first is that the rates we have found are statistically significant; a considerably greater sample size would usually be needed in order to detect the numbers we have found -although again our sample sizes are small. The second reason we present our data is a practical one: cases of pathology are usually excluded from MRI study populations as soon as they are detected. Therefore, they often do not appear in the literature and so remain unknown outside the research group. We have published our data because we judge it important that other researchers working in this area are aware of our cases, and so might not overlook future neurological abnormalities, should they ever be discovered. If a meaningful link between synaesthesia and MS did exist, and as scanning of synaesthetes for research purposes becomes more commonplace, further cases of this nature would arise, and so we encourage researchers to make any cases known to the wider community if they share similarities with our own.
One explanation for a link between synaesthesia and MS could be the occurrence of synaesthesia-like symptoms after the onset of MS. In other words, it is possible that the degenerative neurological damage caused by MS might give rise to sensory disorders that mimic synaesthesia, while having different causes. Sensory disturbances do accompany MS (e.g., changes in colour vision; Gregori et al., 2011) although this hypothesis would imply that the onset of synaesthesia-like symptoms should be later in life --resulting from MSrelated changes in brain structure. However, we do not believe this accounts for the cases we present here, and for two reasons. Later-acquired synaesthesias are qualitatively different to developmental variants (Ward, 2013) and do not reflect the synaesthesias of our participants.
Acquired variants of synaesthesia tend to involve low-level sensory triggers (e.g., tones)
rather than learned symbols such as graphemes (Ward, 2013) although it is precisely this latter type of trigger (graphemes etc.) that our own cases possess -and which might therefore be considered a hallmark of developmental synaesthesia. Furthermore, all three of our cases report life-long synaesthesia, stemming back from early childhood, and being present for as long as they can remember.
Finally, we point out one recent finding that might be considered alongside our own. Bashir, Lipton, Ashina and Ashina (2013) have shown white matter abnormalities in people suffering migraine, especially those for whom the migraine is accompanied by auras. Migraine has been linked with synaesthesia (e.g., Alstadhaug & Benjaminsen, 2010) and the auras associated with migraine are visual disturbances which themselves might be considered as resembling certain types of synaesthetic sensations (e.g., coloured photisms). Future studies might therefore further explore any possible links between synaesthesia and migraine and the types of visual disturbances they each engender.
In conclusion to the current study, we have demonstrated an apparent statistical link between MS-RIS and synaesthesia. Overall, we have been conservative in our study in three ways: we selected baselines in an overly conservative way; we took additional measures to be conservative when conducting our statistical analysis (e.g., assuming no anomalies in scans not assessed by radiologists); and we are circumspect in the interpretation of our findings.
Because our study relies on a small number of cases -three only --we do not claim that any causal link exists between synaesthesia and MS-RIS, and we present our findings with this strong caveat. Nonetheless, we present these significant data so that imaging researchers might consider them when evaluating any anomalies that may arise in future studies. If our epidemiological findings are indeed later supported by additional evidence, this could invite a debate about the clinical status of synaesthesia, which has previously been associated with largely beneficial rather than unfavourable characteristics (but see Carruthers et al., 2012) . In order to investigate this hypothesis further, we are currently also exploring whether developmental synaesthesia is found in high numbers within populations of people with MS, which would enable firmer conclusions to be drawn regarding the validity or otherwise of the statistical associations we report here. 
